A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML) - Interim analysis of 1.5 µci/kg/dose Meeting Abstract
| Authors: | Atallah, E. L.; Orozco, J. J.; Craig, M.; Levy, M. Y.; Finn, L. E.; Khan, S. S.; Perl, A. E.; Park, J. H.; Roboz, G. J.; Tse, W.; Begna, K. H.; Mawad, R.; Rizzieri, D. A.; Berger, M. S.; Jurcic, J. G. |
| Abstract Title: | A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML) - Interim analysis of 1.5 µci/kg/dose |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837604128 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-111951 |
| Notes: | Meeting Abstract: 1457 -- Source: Wos |
